Effects of simvastatin gels on murine calvarial bone

Journal of Periodontology

Volumn 73, Issue 10, 2002, Pages 1141-1148

  Thylin, Michael R ^a   McConnell, Jay C ^a   Schmid, Marian J ^a   Reckling, Ryon R ^a   Ojha, Junu ^a   Bhattaharyya, Indraneel ^a   Marx, David B ^a   Reinhardt, Richard A ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Animal studies; Bone regeneration; Bone, craniofacial; Drug delivery systems; Murine; Simvastatin therapeutic use

Indexed keywords

EOSIN; HEMATOXYLIN; HYPOCHOLESTEROLEMIC AGENT; METHYLCELLULOSE; POLYLACTIDE; SIMVASTATIN;

ANALYSIS OF VARIANCE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE GROWTH; CALVARIA; CLINICAL PROTOCOL; CONTROLLED STUDY; DATA ANALYSIS; DRUG DELIVERY SYSTEM; DRUG EFFECT; FEMALE; GEL; HISTOLOGY; IMAGE ANALYSIS; MEASUREMENT; MOUSE; MOUSE STRAIN; NONHUMAN; PERIODONTAL DISEASE; STAINING; STATISTICAL ANALYSIS; STIMULATION; THICKNESS;

ANALYSIS OF VARIANCE; ANIMALS; ANTICHOLESTEREMIC AGENTS; BONE DENSITY; DRUG DELIVERY SYSTEMS; DRUG IMPLANTS; FEMALE; GELS; INJECTIONS; MEMBRANES, ARTIFICIAL; METHYLCELLULOSE; MICE; MICE, INBRED ICR; OSTEOGENESIS; POLYESTERS; SIMVASTATIN; SKULL;

EID: 0036774235     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2002.73.10.1141     Document Type: Article

References (34)

1. Sigurdsson TJ, Lee MB, Kubota K, Turek TJ, Wozney JM, Wikesjö UME. Periodontal repair in dogs: Recombinant human bone morphogenetic protein-2 significantly enhances periodontal regeneration. J Periodontol 1995; 66:131-138.
2. Sigurdsson TJ, Tatakis DN, Lee MB, Wikesjö UME. Periodontal regenerative potential of space-providing expanded polytetrafluoroethylene membranes and recombinant human bone morphogenetic proteins. J Periodontol 1995;66:511-521.
3. Wozney JM. The potential role of bone morphogenetic proteins in periodontal reconstruction. J Periodontol 1995;66:506-510.
4. Cochran DL, Schenk R, Buser D, Wozney JM, Jones AA. Recombinant human bone morphogenetic protein-2 stimulation of bone formation around endosseous dental implants. J Periodontol 1999;70:139-150.
5. Isobe M, Yamazaki Y, Mori M, Ishihara K, Nakabayashi N, Amagasa T. The role of recombinant human bone morphogenetic protein-2 in PLGA capsules at an extraskeletal site of the rat. J Biomed Mater Res 1999; 45:36-41.
6. Matsumoto A, Yamajik K, Kawanami M, Kato H. Effect of aging on bone formation induced by recombinant human bone morphogenetic protein-2 combined with fibrous collagen membranes at subperiosteal sites. J Periodont Res 2001;36:175-182.
7. Saito N, Okada T, Horiuchi H, et al. Biodegradable poly-D, L-lactic acid-polyethylene glycol block copolymers as a BMP delivery system for inducing bone. J Bone Joint Surg Am 2001;83(A Suppl. 1):S92-S98.
8. Kimoto T, Hosokawa R, Kubo T, Maeda M, Sano A, Akagawa Y. Continuous administration of basic fibroblast growth factor (FGF-2) accelerates bone induction on rat calvaria-an application of a new drug delivery system. J Dent Res 1998;77:1965-1969.
9. Okazaki H, Kurokawa T, Nakamura K, Matsushita T, Mamada K, Kawaguchi H. Stimulation of bone formation by recombinant fibroblast growth factor-2 in callotasis bone lengthening of rabbits. Calcif Tissue Int 1999;64: 542-546.
10. Kawaguchi H, Nakamura K, Tabata Y, et al. Acceleration of fracture healing in nonhuman primates by fibroblast growth factor-2. J Clin Endocrinol Metab 2001;86: 875-880.
11. Boyne PJ, Marx RE, Nevins M, et al. A feasibility study evaluating rhBMP-2/absorbable collagen sponge for maxillary sinus floor augmentation. Int J Periodontics Restorative Dent 1997;17:10-25.
12. Howell TH, Fiorellini J, Jones A, et al. A feasibility study evaluating rhBMP-2/absorbable collagen sponge device for local alveolar ridge preservation or augmentation. Int J Periodontics Restorative Dent 1997;17:124-139.
13. Garrett IR, Gutierrez G, Mundy GR. Statins and bone formation. Curr Pharm Design 2001;7:751-756.
14. Meraw SJ, Reeve CM. Qualitative analysis of peripheral peri-implant bone and influence of alendronate sodium on early bone regeneration. J Periodontol 1999;70:1228-1233.
15. Binderman I, Adut M, Yaffe A. Effectiveness of local delivery of alendronate in reducing alveolar bone loss following periodontal surgery in rats. J Periodontol 2000; 71:1236-1240.
16. Kaynak D, Meffert R, Günhan M, Günhan O, Ozkaya O. A histopathological investigation on the effects of the bisphosphonate alendronate on the resorptive phase following mucoperiosteal flap surgery in the mandible of rats. J Periodontol 2000;71:790-796.
17. Mundy G, Garrett R, Harris S, et al. Stimulation of bone formation in vitro and in rodents by statins. Science 1999;286:1946-1949.
18. Crump TB, Wimmer KL, Reinhardt AL, et al. Effects of locally-delivered human macrophage products and estrogen on murine inflammatory bone resorption. J Periodont Res 2002;37:101-109.
19. Maeda T, Matsunuma A, Kawane T, Horiuchi N. Simvastatin promotes osteoblast differentiation and mineralization in MC3T3-E1 cells. Biochem Biophys Res Commun 2001;280:874-877.
20. Phillips BW, Belmonte N, Vernochet C, Ailhaud C, Dani C. Compactin and simvastatin, but not pravastatin, induce bone morphogenetic protein-2 in human osteosarcoma cells. Biochem Biophys Res Commun 2000;271:688-692.
21. Groeneveld EH, Burger EH. Bone morphogenetic proteins in human bone regeneration. Eur J Endocrinol 2000;142:9-21.
22. Wang JS, Aspenberg P. Basic fibroblast growth factor and bone induction in rats. Acta Orthopaed Scand 1993;64:557-561.
23. Hanada K, Dennis JE, Caplan AI. Stimulatory effects of basic fibroblast growth factor and bone morphogenetic protein-2 on osteogenic differentiation of rat bone marrow-derived mesenchymal stem cells. J Bone Miner Res 1997;12:1606-1614.
24. 1. Bone 1996;19:581-588.
25. Fromigue O, Marie PJ, Lomri A. Bone morphogenetic protein-2 and transforming growth factor-beta 2 interact to modulate human bone marrow stromal cell proliferation and differentiation. J Cell Biochem 1998;68:411-426.
26. Takuwa Y, Ohse C, Wang EA, Wozney JM, Yamashita K. Bone morphogenetic protein-2 stimulates alkaline phosphatase activity and collagen synthesis in cultured osteoblastic cells MC3T3-E1. Biochem Biophys Res Commun 1991;174:96-101.
27. Fisher JE, Rodan GA, Reszka AA. In vivo effect of bisphosphonates on osteoclast mevalonate pathway. Endocrinology 2000;141:4793-4796.
28. Dunstan CR, Boyce R, Boyce BF, et al. Systemic administration of acidic fibroblast growth factor (FGF-1) prevents bone loss and increases new bone formation in ovariectomized rats. J Bone Miner Res 1999;14:953-959.
29. Chung Y-S, Lee M-D, Lee S-K, Kim H-M, Fitzpatrick LA. HMG-CoA reductase inhibitors increase BMD in type 2 diabetes mellitus patients. J Clin Endocrinol Metab 2000;85:1137-1142.
30. Chan KA, Andrade SE, Boles M, et al. Inhibitors of hydroxymethylglutaryl-coenzyme A reductase and risk of fracture among older women. Lancet 2000;355:2185-2188.
31. Wang PS, Solomon DH, Mogun H, Avorn J. HMG-CoA reductase inhibitors and the risk of hip fractures in elderly patients. JAMA 2000;283:3211-3216.
32. Ikeda U, Shimada K. Statins and monocytes (letter). Lancet 1999;353:2070.
33. Lefer AM, Campbell B, Shin YK, Scalia R, Hayward R, Lefer DJ. Simvastatin preserves the ischemic-reperfused myocardium in normocholesterolemic rat hearts. Circulation 1999;100:178-184.
34. Boyne BF, Aufdemorte TB, Garrett IR, Yates AJP, Mundy GR. Effects of interleukin-1 on bone turnover in normal mice. Endocrinology 1989;125:1142-1150.